a<p>Total costs (2009 USD) to vaccinate a target population of 49,980 people;</p>b<p>Mean costs (2009 USD) per fully immunized individual based on actual coverage (50%);</p>c<p>Based on actual expenditure or planned budget data from 2009 mass vaccination campaign, see supporting information (<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001844#pntd.0001844.s005" target="_blank">Table S2</a>) for more details.</p
BackgroundCholera remains an important public health problem in major cities in Bangladesh, especial...
BACKGROUND:Cholera remains an important public health problem in major cities in Bangladesh, especia...
Incremental cost-effectiveness ratios (cost per DALY averted) for vaccination of 1–14 year olds with...
Background: The World Health Organization (WHO) recommends oral cholera vaccines (OCVs) as a supplem...
Use of the oral cholera vaccine (OCV) is a vital short-term strategy to control cholera in endemic a...
Abstract Background Cholera is a diarrheal disease that produces rapid dehydration. The infection is...
IntroductionIn 2016, for the very first time, the Ministry of Health in Zambia implemented a reactiv...
a<p>Mean costs per treated patient at each CTC;</p>b<p>Mean costs per treated patient from patient i...
We conducted a study to assess the feasibility and the potential vaccine coverage of a mass vaccinat...
<p>Base-case results from population of 50,000, with 3% annual discounting of effects.</p>a<p>Costs ...
In this article, we review the feasibility of mass vaccination against cholera and estimate the glob...
The objective of this study was to describe a mass-immunization campaign of a locally-produced oral,...
Cost per DALY averted from cholera vaccination against the GDP per capita in Bangladesh, by program ...
BACKGROUND:Cholera causes an estimated 100,000 deaths annually worldwide, with the majority of burde...
ABSTRACTObjectivesWe evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and use...
BackgroundCholera remains an important public health problem in major cities in Bangladesh, especial...
BACKGROUND:Cholera remains an important public health problem in major cities in Bangladesh, especia...
Incremental cost-effectiveness ratios (cost per DALY averted) for vaccination of 1–14 year olds with...
Background: The World Health Organization (WHO) recommends oral cholera vaccines (OCVs) as a supplem...
Use of the oral cholera vaccine (OCV) is a vital short-term strategy to control cholera in endemic a...
Abstract Background Cholera is a diarrheal disease that produces rapid dehydration. The infection is...
IntroductionIn 2016, for the very first time, the Ministry of Health in Zambia implemented a reactiv...
a<p>Mean costs per treated patient at each CTC;</p>b<p>Mean costs per treated patient from patient i...
We conducted a study to assess the feasibility and the potential vaccine coverage of a mass vaccinat...
<p>Base-case results from population of 50,000, with 3% annual discounting of effects.</p>a<p>Costs ...
In this article, we review the feasibility of mass vaccination against cholera and estimate the glob...
The objective of this study was to describe a mass-immunization campaign of a locally-produced oral,...
Cost per DALY averted from cholera vaccination against the GDP per capita in Bangladesh, by program ...
BACKGROUND:Cholera causes an estimated 100,000 deaths annually worldwide, with the majority of burde...
ABSTRACTObjectivesWe evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and use...
BackgroundCholera remains an important public health problem in major cities in Bangladesh, especial...
BACKGROUND:Cholera remains an important public health problem in major cities in Bangladesh, especia...
Incremental cost-effectiveness ratios (cost per DALY averted) for vaccination of 1–14 year olds with...